Brain Connectivity Marker for Alzheimer's Disease
Clinical Application of a Brain Connectivity Marker for Early Detection of Alzheimer's Disease
Karolinska Institutet
120 participants
Apr 1, 2023
OBSERVATIONAL
Conditions
Summary
The main purpose of this project is to establish whether changes in brain connectivity can be used to predict the development of Alzheimer's disease (AD).
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The investigators will collect imaging sequence, cognitive test scores, clinical data and biofluid samples
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06874231